QURE Clinical Utility
- Accelerate bringing new products to market
- Provide evidence of clinical utility
- Reduce costs and time associated with patient recruitment
- Links behavior change and intervention impact directly to patient outcomes
Built by Clinicians for Clinicians
Our team of doctors and data scientists developed QURE’s simulations to strategically target areas of clinical focus. All cases undergo extensive rounds of edits with the client to ensure accuracy and alignment with that organization’s practice and goals. As these are virtual patients, clients have complete control over their presentation and disease course.
This has broad applicability across:
- All medical specialties
- A variety of diseases states: from the most common to the rarest of conditions
- All clinician types: physicians, nurses, physician assistants, pharmacists, etc.
- Many venues of care: hospitals and health systems, medical groups, accountable care organizations, and health plans, as well as national health systems in developing countries
Continuous Measurement & Feedback
Personalized Feedback
Application for Payers and Providers
QURE’s simulated patient platform measures clinical practice against evidence-based guidelines and provides personalized feedback based on the clinician’s selections in addition to ranking them against their peers.
The clinicians complete weekly cases that are administered in four sessions over the course of a year and includes testing of initial workup, triage, diagnosis, treatment, and follow up skills. Cases take 30 minutes or less to complete and can be done on a phone, tablet, or computer.
Life Science Application
For our life science clients, this may take the form of a randomized controlled trial:
Round 1: Demonstrates the existing variability and practice gaps in diagnosis and treatment of a condition of interest.
Round 2: Demonstrates difference in diagnosis and/or treatment for intervention arm(s) given access to new life-science product.
Related Scientific Papers
Healthcare (2021): Initiative to Improve Evidence-Based Chronic Obstructive Pulmonary Disease Hospitalist Care
Journal of Medical Internet Research (2021): Measuring and Improving Evidence-Based Patient Care
BMJ Innovations (2020): Postmortems on Diagnostic Testing Start-Ups: Reports of Commercial Success and Failures and the Case of the Zombie Life Science Company
American Journal of Clinical Oncology (2019): Clinical Utility of a Blood-based Protein Assay on Diagnostic Colonoscopy Referrals for Elevated-Risk Colorectal Cancer Patients in Primary Care
BMJ Quality and Safety (2019): Standardising Hospitalist Practice in Sepsis and COPD Care
Clinical Breast Cancer (2019): A Better Pathway? Building Consensus and Engaging Providers with Feedback to Improve and Standardize Cancer Care
International Urology and Nephrology (2020): Randomized Clinical Trial of a Novel Donor-Derived cfDNA Test to Detect Rejection in CPV-Simulated Renal Transplant Patients
International Journal of Nephrology (2019): Variation in Assessing Renal Allograft Rejection: A National Assessment of Nephrology Practice
Diagnostics (2019): Establishing Clinical Utility for Diagnostic Tests Using a Randomized Controlled, Virtual Patient Trial Design
Related Solutions
QURE Care Transformation
- Reduces variation in clinical practice
- Serially measures and delivers evidence-based feedback
- Improve performance on quality measures